PL3244889T3 - Kompozycja farmaceutyczna do leczenia grzybicy - Google Patents

Kompozycja farmaceutyczna do leczenia grzybicy

Info

Publication number
PL3244889T3
PL3244889T3 PL16700189T PL16700189T PL3244889T3 PL 3244889 T3 PL3244889 T3 PL 3244889T3 PL 16700189 T PL16700189 T PL 16700189T PL 16700189 T PL16700189 T PL 16700189T PL 3244889 T3 PL3244889 T3 PL 3244889T3
Authority
PL
Poland
Prior art keywords
mycosis
treatment
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
PL16700189T
Other languages
English (en)
Inventor
Claudio Milanese
Alessandra CAPEZZONE DE JOANNON
Serena Tongiani
Luca Donati
Original Assignee
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. filed Critical Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A.
Publication of PL3244889T3 publication Critical patent/PL3244889T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
PL16700189T 2015-01-13 2016-01-08 Kompozycja farmaceutyczna do leczenia grzybicy PL3244889T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15150904 2015-01-13
PCT/EP2016/050272 WO2016113194A1 (en) 2015-01-13 2016-01-08 Pharmaceutical composition for the treatment of mycosis
EP16700189.0A EP3244889B1 (en) 2015-01-13 2016-01-08 Pharmaceutical composition for the treatment of mycosis

Publications (1)

Publication Number Publication Date
PL3244889T3 true PL3244889T3 (pl) 2020-11-02

Family

ID=52396443

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16700189T PL3244889T3 (pl) 2015-01-13 2016-01-08 Kompozycja farmaceutyczna do leczenia grzybicy

Country Status (29)

Country Link
US (1) US9962372B2 (pl)
EP (1) EP3244889B1 (pl)
JP (1) JP6714597B2 (pl)
KR (1) KR102606081B1 (pl)
CN (1) CN107106690B (pl)
AR (1) AR103381A1 (pl)
AU (1) AU2016208200B2 (pl)
BR (1) BR112017014295B1 (pl)
CA (1) CA2970060C (pl)
CY (1) CY1122979T1 (pl)
DK (1) DK3244889T3 (pl)
EA (1) EA035748B1 (pl)
ES (1) ES2794824T3 (pl)
GE (1) GEP20196962B (pl)
HK (1) HK1246146A1 (pl)
HR (1) HRP20200815T1 (pl)
HU (1) HUE049877T2 (pl)
IL (1) IL252774A0 (pl)
LT (1) LT3244889T (pl)
MD (1) MD3244889T2 (pl)
ME (1) ME03736B (pl)
MX (1) MX2017008879A (pl)
PL (1) PL3244889T3 (pl)
PT (1) PT3244889T (pl)
RS (1) RS60508B1 (pl)
SG (1) SG11201704964RA (pl)
SI (1) SI3244889T1 (pl)
UA (1) UA120864C2 (pl)
WO (1) WO2016113194A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA037435B1 (ru) * 2016-07-08 2021-03-26 Ацьенде Кимике Рьюните Анджелини Франческо А.К.Р.А.Ф. С.П.А. Фармацевтическая композиция, содержащая бензидамин
CN112514904B (zh) * 2021-01-26 2021-10-26 青岛农业大学 盐酸苄达明在制备用于防治由植物病原菌引起的植物病害的杀菌剂中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9224598D0 (en) 1992-11-24 1993-01-13 Smithkline Beecham Plc Novel compositions
IT1274655B (it) * 1995-02-28 1997-07-18 Smithkline Beecham Farma Composizioni farmaceutiche contenenti un agente antiinfiammatorio e un agente antimicrobico
US6913759B2 (en) * 2003-03-11 2005-07-05 Curatek Pharmaceuticals Holding, Inc. Gel composition and method for treatment of vaginal infections
PL2018164T3 (pl) * 2006-05-12 2017-08-31 Christian Noe Zastosowanie preparatów złożonych obejmujących środki przeciwgrzybicze
CN1887352A (zh) * 2006-07-13 2007-01-03 徐艳 治疗眼部真菌和细菌感染的组合物
GB201000196D0 (en) * 2010-01-07 2010-02-24 Galvez Julian M Novel combination

Also Published As

Publication number Publication date
PT3244889T (pt) 2020-06-04
JP2018501277A (ja) 2018-01-18
CY1122979T1 (el) 2021-10-29
US9962372B2 (en) 2018-05-08
HUE049877T2 (hu) 2020-10-28
GEP20196962B (en) 2019-04-10
CA2970060A1 (en) 2016-07-21
EA035748B1 (ru) 2020-08-05
EA201791483A1 (ru) 2017-11-30
AU2016208200B2 (en) 2020-09-03
WO2016113194A1 (en) 2016-07-21
AU2016208200A1 (en) 2017-06-29
EP3244889B1 (en) 2020-03-04
ME03736B (me) 2021-01-20
SI3244889T1 (sl) 2020-08-31
AR103381A1 (es) 2017-05-03
MX2017008879A (es) 2018-03-28
JP6714597B2 (ja) 2020-06-24
CA2970060C (en) 2023-10-03
RS60508B1 (sr) 2020-08-31
EP3244889A1 (en) 2017-11-22
BR112017014295B1 (pt) 2023-04-25
MD3244889T2 (ro) 2020-06-30
HRP20200815T1 (hr) 2020-08-07
CN107106690B (zh) 2020-11-10
SG11201704964RA (en) 2017-07-28
US20180000783A1 (en) 2018-01-04
HK1246146A1 (zh) 2018-09-07
ES2794824T3 (es) 2020-11-19
CN107106690A (zh) 2017-08-29
KR102606081B1 (ko) 2023-11-24
LT3244889T (lt) 2020-08-10
IL252774A0 (en) 2017-08-31
BR112017014295A2 (pt) 2018-03-06
UA120864C2 (uk) 2020-02-25
DK3244889T3 (da) 2020-06-02
KR20170101941A (ko) 2017-09-06

Similar Documents

Publication Publication Date Title
IL290823A (en) Pharmaceutical preparations for combination therapy
IL268316B (en) Pharmaceutical preparations for combined treatment
IL265360B (en) Pharmaceutical composition
IL265260B (en) pharmaceutical preparations
IL262654A (en) Pharmacy preparation
IL265349A (en) Pharmaceutical composition
HUE046729T2 (hu) Mirabegront tartalmazó gyógyszerkészítmény
IL261278A (en) Pharmaceutical compositions for the treatment of cancer
IL263040A (en) Pharmaceutical composition comprising eteplirsen
GB201521462D0 (en) Pharmaceutical composition
GB201515310D0 (en) Pharmaceutical composition
PL3454838T3 (pl) Kompozycja farmaceutyczna
GB201615917D0 (en) Pharmaceutical composition
HK1246146A1 (zh) 用於治療真菌病的藥物組合物
GB201520862D0 (en) Pharmaceutical composition
GB201615910D0 (en) Pharmaceutical composition
GB201615914D0 (en) Pharmaceutical composition
IL265436B (en) Pharmacy preparation
HUE057830T2 (hu) Famitinib tartalmú gyógyszerkészítmény
PL3164110T3 (pl) Kompozycje farmaceutyczne do leczenia łuszczycy
IL265428A (en) Pharmaceutical composition
PT3476391T (pt) Composição farmacêutica que compreende arginina para utilização no tratamento da doença de poliq
GB201714241D0 (en) Pharmaceutical compositions for the treatment of proteinopathies
GB201620515D0 (en) Pharmaceutical composition
GB201620513D0 (en) Pharmaceutical composition